Filter
78
Filtered Results: 78
Text search:
sinovac
Featured
Recommendations
7
New Publications
29
Language
Document type
Guidelines
26
Studies & Reports
16
Fact sheets
12
Manuals
7
Strategic & Response Plan
6
No document type
4
Situation Updates
3
Resource Platforms
3
Training Material
1
Countries / Regions
Latin America and the Carribbean
8
Brazil
8
Ecuador
6
Chile
5
Colombia
4
Ukraine
4
Paraguay
4
Germany
3
Argentina
3
Russia
3
El Salvador
2
Spain
2
Mexico
1
Peru
1
Africa
1
Dominican Republic
1
Venezuela
1
South–East Asia Region
1
Western and Central Europe
1
Bolivia
1
Nicaragua
1
Honduras
1
Liberia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
COVID-19
34
Guidelines
19
Studies & Reports
6
Vaccine-preventable Diseases
4
Policies
2
Statistics
2
Immunization
2
Hepatitis
1
Pharmacy & Technology
1
Annual Report MEDBOX
1
x MEDBOX Issue Brief & Annual Reports x
1
Pediatrics
1
Medical Devices & Equipment
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Humanitarian Crisis
1
Mental Health
1
Toolboxes
Country specific documents
23
Immunization Guidelines
8
Communication Material
7
Inactivated COVID-19 Vaccines
7
Hospital Readiness/Essential Health Services
5
Booster Doses
5
Clinical Guidelines
4
For Health Worker
4
Fair Allocation & Ethical Aspects
3
Information Refugees Ukraine
3
Vaccination
2
Poster & Infographics
2
For General Public & Community
2
Access & Strategy
2
SARS-CoV-2 Variants
2
Vaccine Hesitancy & Myths
2
Johnson & Johnson
2
Integration
1
Assessment & Studies
1
Pediatrics
1
Germany
1
COVID-19
1
Surveillance & Contact tracing
1
For Parents & Children
1
For Pregnant Women
1
Training, others
1
Appeals and Response Plans
1
Dashboards & Maps
1
Global Impact: Socio-economic, health services, TB & HIV
1
Information for the Public
1
Country-specific Platforms
1
Paediatrics
1
Mythbusters/Misinformation
1
Tips & Best Practice Examples
1
Vaccination & Strategy
1
COVID-19 Vaccination
1
Dashboards & Resource Platforms
1
Logistics & Supply
1
COVAX Initiative
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Vector-based Vacines General
1
Vaxzevria (Astra Zeneca)
1
Sputnik V
1
Research & Pipeline
1
Chile
1
Essential Medicines
1
Rational use of Medicine
1
Pharmacovigilance
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Information, Resources & Websites
1
General
1
COVID-19
1
Romania
1
Miscellaneous
1
Public Health Administration
1
Orientation Guides
1
Refugees & Migrants
1
Action Plans, Policies & Response
1
Depression
1
Volunteers
1
Country Specific Information
1
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
Вакцина против COVID-19 CoronaVac производства компании Sinovac (Sinovac-CoronaVac) July 2021
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell ...
11 august 2022, updated version
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
